Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Accumulated Expenses (2016 - 2025)

GeoVax Labs' Accumulated Expenses history spans 16 years, with the latest figure at $882816.0 for Q4 2025.

  • Quarterly results put Accumulated Expenses at $882816.0 for Q4 2025, down 29.8% from a year ago — trailing twelve months through Dec 2025 was $882816.0 (down 29.8% YoY), and the annual figure for FY2025 was $882816.0, down 29.8%.
  • Accumulated Expenses for Q4 2025 was $882816.0 at GeoVax Labs, up from $847766.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.7 million in Q3 2022 to a low of $36623.0 in Q1 2021.
  • The 5-year median for Accumulated Expenses is $1.3 million (2024), against an average of $1.7 million.
  • The sharpest move saw Accumulated Expenses crashed 98.09% in 2021, then surged 8296.36% in 2022.
  • Year by year, Accumulated Expenses stood at $3.4 million in 2021, then decreased by 11.18% to $3.0 million in 2022, then plummeted by 76.1% to $716931.0 in 2023, then soared by 75.41% to $1.3 million in 2024, then fell by 29.8% to $882816.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $882816.0, $847766.0, and $699076.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.